Shares of Reitmans Limited (TSE:RET – Get Free Report) traded down 3.6% on Monday . The company traded as low as C$0.25 and last traded at C$0.27. 22,200 shares changed hands during trading, a decline of 9% from the average session volume of 24,407 shares. The stock had previously closed at C$0.28.
Reitmans Stock Performance
The business’s 50 day simple moving average is C$0.27. The firm has a market cap of C$13.19 million and a price-to-earnings ratio of -0.09. The company has a current ratio of 1.10, a quick ratio of 0.26 and a debt-to-equity ratio of 188.87.
Insider Buying and Selling at Reitmans
In other news, Senior Officer Richard Wait sold 20,000 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of C$2.50, for a total value of C$50,000.00. Also, Senior Officer Alain Murad sold 17,000 shares of Reitmans stock in a transaction that occurred on Wednesday, September 25th. The stock was sold at an average price of C$2.56, for a total value of C$43,579.50. Insiders have sold a total of 81,700 shares of company stock worth $211,484 over the last ninety days.
Reitmans Company Profile
Reitmans (Canada) Limited primarily engages in the retail of women's wearing apparel in Canada. Its products include shirts, blouses, pants, dresses, skirts, sweaters, outerwear, activewear, lingerie, and accessories. The company also offers apparel for men. It serves customers through retail and e-commerce channels, under the Reitmans, Addition Elle, Penningtons, RW & CO., Thyme Maternity, and Hyba brand names.
Read More
- Five stocks we like better than Reitmans
- The 3 Best Fintech Stocks to Buy Now
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What is the Australian Securities Exchange (ASX)
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Reitmans Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reitmans and related companies with MarketBeat.com's FREE daily email newsletter.